Compare Mutual Funds
Select a Mutual Fund
Risk | Very High | - |
Rating | 2.0 | - |
Min SIP Amount | ₹99 | - |
Expense Ratio | 1.94 | - |
NAV | ₹36.39 | - |
Fund Started | 11 Jun 2018 | - |
Fund Size | ₹2770.84 Cr | - |
Exit Load | Exit load of 1% if redeemed within 1 year. | - |
Risk
Very High
-
Rating
2.0
-
Min SIP Amount
₹99
-
Expense Ratio
1.94
-
NAV
₹36.39
-
Fund Started
11 Jun 2018
-
Fund Size
₹2770.84 Cr
-
Exit Load
Exit load of 1% if redeemed within 1 year.
-
1 Year | -2.19% | - |
3 Year | 19.86% | - |
5 Year | 14.24% | - |
1 Year
-2.19%
-
3 Year
19.86%
-
5 Year
14.24%
-
Equity | 99.46% | - |
Cash | 0.54% | - |
Equity
99.46%
-
Cash
0.54%
-
Top 10 Holdings |
| - |
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 12.44% |
Divi's Laboratories Ltd. | 8.57% |
Glenmark Pharmaceuticals Ltd. | 6.91% |
Apollo Hospitals Enterprise Ltd. | 5.80% |
Cipla Ltd. | 5.55% |
Lupin Ltd. | 5.23% |
Dr. Reddy's Laboratories Ltd. | 4.34% |
Aurobindo Pharma Ltd. | 4.24% |
Fortis Healthcare Ltd. | 4.22% |
Ipca Laboratories Ltd. | 3.46% |
-
Name | - | - |
Start Date | - | - |
Name
-
-
Start Date
-
-
Description | The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sectors in India. | - |
Launch Date | 11 Jun 2018 | - |
Description
The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sectors in India.
-
Launch Date
11 Jun 2018
-